<DOC>
	<DOCNO>NCT00754871</DOCNO>
	<brief_summary>This study investigate mechanism action Dienogest . The growth follicle , endometrium , hormone blood mucus produce cervix look upon . Four different dosage Dienogest ( 0.5 mg , 1 mg , 2 mg 3 mg ) investigate healthy young woman two cycle , maximum 72 day .</brief_summary>
	<brief_title>Pharmacodynamic Characterization Dienogest</brief_title>
	<detailed_description />
	<mesh_term>Dienogest</mesh_term>
	<mesh_term>Nandrolone</mesh_term>
	<criteria>Signed informed consent BodyMassIndex ( BMI ) : 18 30 kg/mÂ² Healthy female volunteer Age 1835 year ( smoker old 30 year , inclusive ) At least 3 month since delivery , abortion lactation Willingness use nonhormonal method contraception entire study Contraindications use progesteroneonly pill combine oral contraceptive ( e.g . history venous/arterial thromboembolic disease ) Use systemic topical medication substance oppose study objective might influence within 4 week prior start pretreatment cycle Clinically relevant finding ( blood pressure , physical gynecological examination , laboratory examination )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>